July 29, 2019 09:50 AM EDT

Genfit's elafibranor wins orphan status for primary biliary cholangitis; Cidara stock soars on positive anti-fungal mid-stage data

Natalie Grover

Reporter

→ NASH hopeful Genfit has been awarded orphan drug status by US and EU regulators for its experimental drug, elafibranor, to treat patients with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Genfit's elafibranor wins orphan status for primary biliary cholangitis; Cidara stock soars on positive anti-fungal mid-stage data

Natalie Grover

Reporter

Sign up to read this article for free.

Novartis turns to BioAge for new targets based on longevity and exercise

Merck’s long-awaited obesity move is an oral GLP-1 from China

Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs

Post-Hoc: Biosecure is dead. Long live Biosecure?

Novo Nordisk partners with Broad Institute spinout Photys after the startup's layoffs

US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total

Gen­fit's elafi­bra­nor wins or­phan sta­tus for pri­ma­ry bil­iary cholan­gi­tis; Cidara stock soars on pos­i­tive an­ti-fun­gal mid-stage da­ta

Natalie Grover

Reporter

Sign up to read this article for free.

more like this

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

Post-Hoc: Biose­cure is dead. Long live Biose­cure?

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

US spent $450B on drugs last year, CMS says, with new obe­si­ty and di­a­betes drugs adding to to­tal

Genfit's elafibranor wins orphan status for primary biliary cholangitis; Cidara stock soars on positive anti-fungal mid-stage data

Novartis turns to BioAge for new targets based on longevity and exercise

Merck’s long-awaited obesity move is an oral GLP-1 from China

Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs

Post-Hoc: Biosecure is dead. Long live Biosecure?

Novo Nordisk partners with Broad Institute spinout Photys after the startup's layoffs

US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total